Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Decitabine and Talazoparib in Untreated AML and R/R AML
ClinicalTrials.gov study NCT02878785. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Phase I/II - Brentuximab/5-Azacytidine in Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02096042. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS
ClinicalTrials.gov study NCT01607645. IPD Sharing: YES. Countries: 1. Publications: 0.
CLAG Gleevec in Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00955916. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00831766. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Clofarabine in Older Patients With Acute Myeloid Leukemia (AML) for Whom Chemotherapy Is Not Suitable
ClinicalTrials.gov study NCT00924443. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Bendamustine and Idarubicin in Treating Older Patients With Previously Untreated AML or MDS
ClinicalTrials.gov study NCT01141725. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clofarabine Pre-conditioning Followed by Stem Cell Transplant for Non-remission AML
ClinicalTrials.gov study NCT04002115. IPD Sharing: NO. Countries: 1. Publications: 0.
Decitabine (DAC) w/ or w/o Valproic Acid (VPA) in Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT00414310. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00822094. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Adoptive Transfer of Haplo-identical DLI for AML and MDS
ClinicalTrials.gov study NCT02046122. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Entospletinib Monotherapy and in Combination With Chemotherapy in Adults With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02343939. IPD Sharing: NO. Countries: 3. Publications: 0.
Phase I/II Study of 5-Azacytidine With Ara-C in Patients With Relapsed/Refractory Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00569010. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study of Pembrolizumab as Post-Remission Treatment of Patients ≥ 60 With AML
ClinicalTrials.gov study NCT02708641. IPD Sharing: NO. Countries: 1. Publications: 0.
A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02632721. IPD Sharing: NO. Countries: 4. Publications: 0.
GLAD-AML - Glasdegib (Pf-04449913) With Two Standard Decitabine Regimens for Older Patients With Poor-risk Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04051996. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of a New Anti-cancer Immunotherapy After Chemotherapy in Adult Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00725283. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Flotetuzumab for Relapsed Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Following Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)
ClinicalTrials.gov study NCT04582864. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01390337. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00656617. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.